Unichem enters settlement pact with Eli Lilly & ICOS Corp for erectile dysfunction drug
Unichem Laboratories today said it has entered into a settlement pact with pharma major Eli Lilly & Company and ICOS Corporation for resolving their patent litigation regarding generic tadalafil used for treating erectile dysfunction.
The patent litigation was in the US District Court for New Jersey, Unichem said.
The company "has entered into a settlement
Disclaimer: No Business Standard Journalist was involved in creation of this content